AtriCure (ATRC) Tops Q2 EPS by 19c; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rallies after Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $64.57 +6.89%
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
ATS, SICP, FTCO, More
Financial Fact:
Income tax expense (benefit): 2K
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.11), $0.19 better than the analyst estimate of ($0.30). Revenue for the quarter came in at $100.9 million versus the consensus estimate of $97.55 million.
GUIDANCE:
AtriCure sees FY2023 EPS of $0.92-$0.94, versus the consensus of ($1.09). AtriCure sees FY2023 revenue of $392-395 million, versus the consensus of $388.4 million.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southwest Gas (SWX) Tops Q3 EPS by 2c; Offers Guidance
- Harmony Biosciences (HRMY) Misses Q3 EPS by 30c; Offers Guidance
- Scotts Miracle-Gro (SMG) Tops Q4 EPS by 5c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
